Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Neutral on HCA Healthcare, Raises Price Target to $332

Author: Benzinga Newsdesk | May 30, 2024 01:45pm
JP Morgan analyst Lisa Gill maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $327 to $332.

Posted In: HCA